Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > McMaster Researchers Find Age Not… >

McMaster Researchers Find Age Not Factor in Immunity to Viruses

Published: December 14, 2012.
Released by McMaster University  

Hamilton, Ont. (Dec. 13, 2012) — Our immune system does not shut down with age, says a new study led by McMaster University researchers.

A study published in PLOS Pathogens today shows a specialized class of immune cells, known as T cells, can respond to virus infections in an older person with the same vigour as T cells from a young person.

"For a long time, it was thought the elderly were at a higher risk of infections because they lacked these immune cells, but that simply isn't the case," said Jonathan Bramson, the study's principal investigator. "The elderly are certainly capable of developing immunity to viruses."

Researchers at McMaster, University of Toronto and the University of Pennsylvania examined individuals, younger than 40, between 41 to 59 years of age and older than 60, infected with three different viruses, including West Nile, and found the older group demonstrated perfectly normal immune responses.

Both the number of virus-fighting T cells and the functionality of the T cells were equivalent in all three groups.

"So as we age, our bodies are still able to respond to new viruses, while keeping us immune to viruses we've been exposed to in the past," Bramson said.

He added that these results have important implications for vaccination of elderly individuals.

Currently, vaccines for the elderly aren't designed to elicit responses from these immune cells, and this might explain the lack of effective protection from the flu vaccine, he said.

Vaccines specifically designed to generate T-cell immunity may be more effective at protecting older adults, Bramson said.




The above story is based on materials provided by McMaster University.

Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


comments powered by Disqus


Related »

Therapy 
1/8/14 
Does the Body's Immune Response to Viral Vector Delivery Systems Affect the Safety Or Efficacy of Gene Therapy?
New Rochelle, NY, January 7, 2014—Packaging replacement genes in viruses is an effective method to deliver them to target tissues, but the human body mounts an immune response against …
Therapy 
6/25/12 
Targeted Gene Therapy Enhances Treatment for Pompe Disease
New Rochelle, NY, June 25, 2012—Gene therapy to replace the protein missing in Pompe disease can be effective if the patient's immune system does not react against the therapy. …
Immune 
3/8/11 
Making Viruses Pass for 'Safe'
WASHINGTON, D.C. (March 8 2011) -- Viruses can penetrate every part of the body, making them potentially good tools for gene therapy or drug delivery. But with our immune …
Viruses 
12/12/10 
Tracing Microbes Between Individuals Towards Personalized Oral Health Care
December 13, 2010 – The human body is home to a complex ecosystem of microbes increasingly recognized as having a critical role in both health and disease. Viruses can …
Shuttle 
10/29/10 
★ 
Shuttle Mice to Boost Disease Research
GALVESTON, Texas — When the space shuttle Discovery lifts off on its final flight Nov. 2, its six astronauts will be joined by 16 rodent passengers on a historic …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile